Stock To Watch: Genesis Healthcare, Inc. (NYSE:GEN)


The leading market experts have placed a mean price target of $2.21 on Genesis Healthcare, Inc. (NYSE:GEN) stock. This price level, which is estimated to be attained in one-year, indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $-0.34 a share for the upcoming quarter and $-1.49 for the current fiscal.

Technical View

The technical analysis of Genesis Healthcare, Inc. Common plainly substantiates that the 50-day moving average of Genesis Healthcare, Inc. Common is $2.16, and stock is trading $0.30 points away or +13.65% from its 50-day moving average of $2.16. Further it is trading $0.37 or +17.60% away its 200-day moving average of $2.09. Genesis Healthcare, Inc. (NYSE:GEN) 52-week high is $7.41 and the 52-week low is $1.38.

This explains if the stock moves $-4.95, it will post a 52-week high. In event of +78.26% decline, a 52-week low will be hit.

Taking the valuation aspect to emphasize the valuation of Genesis Healthcare, Inc. Common, shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Genesis Healthcare, Inc. (NYSE:GEN) ratio came in at N/A.

The stock last ended the trading session at $2.46 and registered a market cap of $221.38M. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Genesis Healthcare, Inc. (NYSE:GEN) PEG ratio is at -0.16.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 24 times, 1 visits today)